Collaborative advance care planning in advanced cancer patients: col-ACP –study – study protocol of a randomised controlled trial
Autor: | Seifart, Carola, Koch, Martin, Leppin, Nico, Nagelschmidt, Katharina, Knorrenschild, Jorge Riera, Timmesfeld, Nina, Rief, Winfried, von Blanckenburg, Pia |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Male
lcsh:RC952-1245 lcsh:Special situations and conditions Middle Aged humanities Study Protocol Clinical Protocols stomatognathic system Complex intervention Neoplasms Surveys and Questionnaires Palliative care Humans Female Longitudinal Studies Patient Participation End of life care Randomized Controlled Trials as Topic Advance care planning Psycho-oncological intervention |
Zdroj: | BMC Palliative Care, Vol 19, Iss 1, Pp 1-10 (2020) BMC Palliative Care |
DOI: | 10.1186/s12904-020-00629-7 |
Popis: | Background To assure patient-centred end-of-life care, palliative interventions need to account for patients’ preferences. Advance care planning (ACP) is a structured approach that allows patients, relatives and physicians to discuss end-of-life decisions. Although ACP can improve several patient related outcomes, the implementation of ACP remains difficult. The col-ACP-study (collaborative advance care planning) will investigate a new ACP procedure (col-ACP-intervention (German: Hand-in-Hand Intervention)) in palliative cancer patients and their relatives that addresses individual values and targets barriers of communication before an ACP process. Methods In a randomised controlled trial, 270 cancer patients without curative treatment options and their relatives will receive either 1) col-ACP 2) a supportive intervention (active control group) or 3) standard medical care (TAU). col-ACP comprises two steps: a) addressing various barriers of patients and relatives that discourage them from discussing end-of-life issues followed by b) a regular, structured ACP procedure. The col-ACP-intervention consists of 6 sessions. Primary endpoint is the patients’ quality of life 16 weeks after randomisation. Secondary endpoints include measurements of distress; depression; communication barriers; caregivers’ quality of life; existence of ACP or advance directives; the consistence of end of life care; and others. Patients will be followed up for 13 months. Multivariate analyses will be carried out. Qualitative evaluation of the intervention will be conducted. Discussion Augmentation of a regular ACP program by a structured psycho-oncological intervention is an innovative approach to target barriers of communication about end-of-life issues. Study findings will help to understand the value of such a combined intervention in palliative care. Trial registration ClinicalTrials.gov Identifier: NCT03387436 (Date of registration: 01/02/2018, retrospectively registered. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |